These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 577497)

  • 1. Thyroxine toxicosis in patients with iodine induced thyrotoxicosis.
    Sobrinho LG; Limbert ES; Santos MA
    J Clin Endocrinol Metab; 1977 Jul; 45(1):25-9. PubMed ID: 577497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum triiodothyronine to thyroxine ratio: a newly recognized predictor of the outcome of hyperthyroidism due to Graves' disease.
    Takamatsu J; Kuma K; Mozai T
    J Clin Endocrinol Metab; 1986 May; 62(5):980-3. PubMed ID: 3754263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease and toxic multinodular goiter.
    Gedik O; Ozdemir T; Akalin S
    Isr J Med Sci; 1991 Jul; 27(7):361-4. PubMed ID: 1712765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
    Larsen PR
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity to lithium in treated Graves' disease: effects on serum T4, T3 and reverse T3.
    Burman KD; Dimond RC; Earll JM; Wright FD; Wartofsky L
    J Clin Endocrinol Metab; 1976 Sep; 43(3):606-13. PubMed ID: 989049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
    Chen JJ; Ladenson PW
    J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3).
    Chopra IJ; Williams DE; Orgiazzi J; Solomon DH
    J Clin Endocrinol Metab; 1975 Nov; 41(5):911-20. PubMed ID: 1242390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T4-thyrotoxicosis.
    Dorfman SG; Young RL
    Arch Intern Med; 1978 Jun; 138(6):1016-7. PubMed ID: 580554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
    Takamatsu J; Hosoya T; Naito N; Yoshimura H; Kohno Y; Tarutani O; Kuma K; Sakane S; Takeda K; Mozai T
    J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Operative indications and surgical procedure in iodine-induced hyperthyroidism].
    Dralle H; Lang W; Pretschner DP; Pichlmayr R; Hesch RD
    Langenbecks Arch Chir; 1985; 365(2):79-89. PubMed ID: 4046686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower serum free thyroxine (T4) levels in painless thyroiditis compared with Graves' disease despite similar serum total T4 levels.
    Shigemasa C; Abe K; Taniguchi S; Mitani Y; Ueda Y; Adachi T; Urabe K; Tanaka T; Yoshida A; Mashiba H
    J Clin Endocrinol Metab; 1987 Aug; 65(2):359-63. PubMed ID: 3110204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of thyroxine thyrotoxicosis.
    Blank MS; Tucci JR
    Arch Intern Med; 1987 May; 147(5):863-4. PubMed ID: 3579439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroxine and 3,5,3'-triiodothyronine content of thyroglobulin in thyroid needle aspirates in hyperthyroidism and hypothyroidism.
    Laurberg P
    J Clin Endocrinol Metab; 1987 May; 64(5):969-74. PubMed ID: 3558731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Excessive peripheral conversion of thyroxine (T4) to triiodothyronine (T3) in the pathogenesis of T3-hyperthyroidism (author's transl)].
    Herrmann J; Lehr HJ; Kröll HJ; Rusche HJ; Rudorff KH; Krüskemper HL
    Dtsch Med Wochenschr; 1975 Nov; 100(45):2319-23. PubMed ID: 52434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short and long term effects of radioiodine and antithyroid drugs on T4 binding proteins, free T4 and T3, during Graves' disease therapy.
    Jaffiol C; Baldet L; Robin M; Papachristou C; Lapinski H; Mirouze J
    Horm Metab Res; 1977 Jan; 9(1):73-81. PubMed ID: 66177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of thyrotoxicosis induced by thyroid destruction from Graves' disease.
    Amino N; Yabu Y; Miyai K; Fujie T; Azukizawa M; Onishi T; Kumahara Y
    Lancet; 1978 Aug; 2(8085):344-6. PubMed ID: 79711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in serum TSH and T4 after T3 suppression tests in patients treated for hyperthyroidism due to Graves' disease.
    Suematsu H; Tamai H; Esaki M; Kurokawa N; Aoki H; Matsuzuka F; Miyauchi A; Kuma K
    J Clin Endocrinol Metab; 1977 Nov; 45(5):1013-8. PubMed ID: 579181
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation of sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine in patients with Graves' disease and subacute thyroiditis.
    Izumi M; Larsen PR
    Metabolism; 1978 Apr; 27(4):449-60. PubMed ID: 580305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of simultaneous T3, T4, and TSH measurements for management of graves' disease in children.
    Golden MP; Kaplan SA; Lippe BM; Lee WN
    Pediatrics; 1977 May; 59(5):762-7. PubMed ID: 577011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The toxic effect of small iodine supplements in patients with autonomous thyroid nodules.
    Livadas DP; Koutras DA; Souvatzoglou A; Beckers C
    Clin Endocrinol (Oxf); 1977 Aug; 7(2):121-7. PubMed ID: 890996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.